Genetic and phenotypic analysis of MYO15A rare variants associated with autosomal recessive hearing loss.
10.13201/j.issn.2096-7993.2024.01.006
- Author:
Yun LIN
1
;
Jun XU
1
;
Tao YANG
1
Author Information
1. Department of Otolaryngology-Head and Neck Surgery，Shanghai Ninth People's Hospital，Shanghai Jiao Tong University School of Medicine，Shanghai，200125，China.
- Publication Type:Journal Article
- Keywords:
Genetic counseling;
Genotype;
Hereditary hearing loss tacilitates;
MYO15A;
Phenotype
- MeSH:
Humans;
Pedigree;
China;
Deafness/genetics*;
Hearing Loss/genetics*;
Phenotype;
Hearing Loss, Sensorineural/genetics*;
Mutation;
Myosins/genetics*
- From:
Journal of Clinical Otorhinolaryngology Head and Neck Surgery
2024;38(1):38-43
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To analyze the phenotype and genotype characteristics of autosomal recessive hearing loss caused by MYO15A gene variants, and to provide genetic diagnosis and genetic counseling for patients and their families. Methods:Identification of MYO15A gene variants by next generation sequencing in two sporadic cases of hearing loss at Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine. The sequence variants were verified by Sanger sequencing.The pathogenicity of these variants was determined according to the American College of Medical Genetics and Genomics（ACMG） variant classification guidelines, in conjuction with clinical data. Results:The probands of the two families have bilateral,severe or complete hearing loss.Four variants of MYO15A were identified, including one pathogenic variant that has been reported, two likely pathogenic variants,and one splicing variant of uncertain significance. Patient I carries c. 3524dupA（p. Ser1176Valfs*14）, a reported pathogenic variant, and a splicing variant c. 10082+3G>A of uncertain significance according to the ACMG guidelines. Patient I was treated with bilateral hearing aids with satisfactory effect, demonstrated average hearing thresholds of 37.5 dB in the right ear and 33.75 dB in the left ear. Patient Ⅱ carries c. 7441_7442del（p. Leu2481Glufs*86） and c. 10250_10252del（p. Ser3417del）,a pair of as likely pathogenic variants according to the ACMG guidelines. Patient Ⅱ, who underwent right cochlear implantation eight years ago, achieved scores of 9 on the Categorical Auditory Performance-Ⅱ（CAP-Ⅱ） and 5 on the Speech Intelligibility Rating（SIR）. Conclusion:This study's discovery of the rare c. 7441_7442del variant and the splicing variant c. 10082+3G>A in the MYO15A gene is closely associated with autosomal recessive hearing loss, expanding the MYO15A variant spectrum. Additionally, the pathogenicity assessment of the splicing variant facilitates classification of splicing variations.
